ANEURISM IV

Vellocet · 2025 · $9.99 · Action · deal grade C

• Estimated net residual revenue: $6.8k to $10.2k per month
• Opportunity: $8.5k per month at x1.00 dormancy
• Estimated lifetime owners: 179.9k
• 76%% positive across 6223 reviews · 101.2 reviews/month

Why it's flagged

• Developer active, last post 1 months ago
• Last build shipped 1 months ago
• Last discounted 0 months ago, 6 sales in the last 12 months

This case as Markdown · Estimates carry ±30-50%% error per title.